Cupps Capital Management’s Boston Scientific BSX Stock Holding History

Cupps Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$4K	Sell	187 -71,431	-100%	-$1.7M	﹤0.01%	159
2016 Q2	$1.67M	Buy	71,618 +17,133	+31%	+$371K	0.43%	86
2016 Q1	$1.02M	Buy	+54,485	New	+$957K	0.2%	124
2015 Q3	–	Sell	-25,886	Closed	-$458K	–	187
2015 Q2	$458K	Buy	25,886 +3,761	+17%	+$67.2K	0.04%	135
2015 Q1	$392K	Buy	+22,125	New	+$350K	0.03%	155
2014 Q2	–	Sell	-270	Closed	-$3K	–	214
2014 Q1	$3K	Buy	+270	New	+$3.54K	﹤0.01%	181
2013 Q4	–	Sell	-270	Closed	-$3K	–	152
2013 Q3	$3K	Buy	+270	New	+$2.92K	﹤0.01%	155

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Cupps Capital Management's BSX Position: Q3 2016 in Review

Cupps Capital Management reduced its Boston Scientific (BSX) stake by 100% in Q3 2016, selling an estimated $1.7M and leaving 187 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #159.

Cupps Capital Management first reported a position in BSX in Q3 2013 and has held it in 7 quarters since. The position peaked at $1.67M in Q2 2016. 566 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

Cupps Capital Management held 187 shares of Boston Scientific worth $4K as of Q3 2016.
Cupps Capital Management sold 71,431 Boston Scientific shares in Q3 2016, an estimated $1.7M.
Boston Scientific made up ﹤0.01% of Cupps Capital Management's portfolio in Q3 2016, its #159 holding.
Cupps Capital Management first reported a position in Boston Scientific in Q3 2013 and has held it in 7 quarters since.
Cupps Capital Management's Boston Scientific position peaked at $1.67M in Q2 2016.
566 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.